IgE in the diagnosis and treatment of allergic disease
- PMID: 27264001
- PMCID: PMC5406226
- DOI: 10.1016/j.jaci.2016.04.010
IgE in the diagnosis and treatment of allergic disease
Abstract
Traditionally, the concept of allergy implied an abnormal response to an otherwise benign agent (eg, pollen or food), with an easily identifiable relationship between exposure and disease. However, there are syndromes in which the relationship between exposure to the relevant allergen and the "allergic" disease is not clear. In these cases the presence of specific IgE antibodies can play an important role in identifying the relevant allergen and provide a guide to therapy. Good examples include chronic asthma and exposure to perennial indoor allergens and asthma related to fungal infection. Finally, we are increasingly aware of forms of food allergy in which the relationship between exposure and the disease is delayed by 3 to 6 hours or longer. Three forms of food allergy with distinct clinical features are now well recognized. These are (1) anaphylactic sensitivity to peanut, (2) eosinophilic esophagitis related to cow's milk, and (3) delayed anaphylaxis to red meat. In these syndromes the immunology of the response is dramatically different. Peanut and galactose α-1,3-galactose (alpha-gal) are characterized by high- or very high-titer IgE antibodies for Ara h 2 and alpha-gal, respectively. By contrast, eosinophilic esophagitis is characterized by low levels of IgE specific for milk proteins with high- or very high-titer IgG4 to the same proteins. The recent finding is that patients with alpha-gal syndrome do not have detectable IgG4 to the oligosaccharide. Thus the serum results not only identify relevant antigens but also provide a guide to the nature of the immune response.
Keywords: Asthma; IgE antibodies; IgG(4); allergen particles; alpha-gal; eosinophilic esophagitis.
Copyright © 2016. Published by Elsevier Inc.
Conflict of interest statement
Disclosure of potential conflict of interest: T. A. E. Platts-Mills has received a grant from ThermoFisher/Phadia. E. A. Erwin is employed by Nationwide Children’s Hospital; has received royalties from UpToDate; and has received travel support from the American College of Allergy, Asthma, and Immunology. S. P. Commins has received personal fees from Genentech and UpToDate and has received a grant from the National Institutes of Health. J. A. Woodfolk has received grants from the National Institutes of Health/National Institute of Allergy and Infectious Diseases and the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases. A. J. Schuyler declares no relevant conflicts of interest.
Figures
References
-
- Von Pirquet C. Translated version. In: Gell PGH, Coombs RRA, Lachmann PJ, editors. Clinical aspects of immunology. Oxford: Blackwell Scientific Publications; 1906.
-
- Prausnitz C, Kustner H. Studien uber die ueberempfinclichkeit. Zentralbl Bakteriol. 1921;86:160.
-
- Ishizaka K, Ishizaka T, Hornbrook M. Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity with gamma-E-globulin antibody. J Immunol. 1966;97:840–53. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
